207 related articles for article (PubMed ID: 18235249)
1. Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.
Zeiser R; Negrin RS
Cell Cycle; 2008 Feb; 7(4):458-62. PubMed ID: 18235249
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road.
Shen Z; Chen L; Hao F; Wu J
Med Res Rev; 2009 Sep; 29(5):742-66. PubMed ID: 19267400
[TBL] [Abstract][Full Text] [Related]
3. Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17
Su Y; Wang Q; Yang B; Wu L; Cheng G; Kuang H
Clin Exp Immunol; 2017 Oct; 190(1):40-53. PubMed ID: 28617942
[TBL] [Abstract][Full Text] [Related]
4. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
[TBL] [Abstract][Full Text] [Related]
5. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.
Bensinger SJ; Walsh PT; Zhang J; Carroll M; Parsons R; Rathmell JC; Thompson CB; Burchill MA; Farrar MA; Turka LA
J Immunol; 2004 May; 172(9):5287-96. PubMed ID: 15100267
[TBL] [Abstract][Full Text] [Related]
6. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
7. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
Ding Y; Yu A; Tsokos GC; Malek TR
J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
[TBL] [Abstract][Full Text] [Related]
8. A Common Druggable Defect in Regulatory T Cells from Patients with Autoimmunity.
Soares L; Yip L; Hurt CR; Fathman G
Crit Rev Immunol; 2020; 40(3):185-193. PubMed ID: 33389883
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Carbone F; De Rosa V; Carrieri PB; Montella S; Bruzzese D; Porcellini A; Procaccini C; La Cava A; Matarese G
Nat Med; 2014 Jan; 20(1):69-74. PubMed ID: 24317118
[TBL] [Abstract][Full Text] [Related]
10. IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function.
Sun H; Lee HS; Kim SH; Fernandes de Lima M; Gingras AR; Du Q; McLaughlin W; Ablack J; Lopez-Ramirez MA; Lagarrigue F; Fan Z; Chang JT; VanDyke D; Spangler JB; Ginsberg MH
Cell Rep; 2023 Aug; 42(8):112996. PubMed ID: 37598341
[TBL] [Abstract][Full Text] [Related]
11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
12. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
15. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
16. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.
Cheng G; Yu A; Malek TR
Immunol Rev; 2011 May; 241(1):63-76. PubMed ID: 21488890
[TBL] [Abstract][Full Text] [Related]
17. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
18. PIP3 pathway in regulatory T cells and autoimmunity.
Kashiwada M; Lu P; Rothman PB
Immunol Res; 2007; 39(1-3):194-224. PubMed ID: 17917066
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients.
Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC
Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764
[TBL] [Abstract][Full Text] [Related]
20. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
Bayer AL; Yu A; Malek TR
J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
